Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation
- 8 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 99 (12), 1394-1402
- https://doi.org/10.1161/01.res.0000252323.83137.fe
Abstract
There is evidence suggesting that heat shock proteins (HSPs) may protect against clinical atrial fibrillation (AF). We evaluated the effect of HSP induction in an in vitro atrial cell line (HL-1) model of tachycardia remodeling and in tachypaced isolated canine atrial cardiomyocytes. We also evaluated the effect of HSP induction on in vivo AF promotion by atrial tachycardia-induced remodeling in dogs. Tachypacing (3 Hz) significantly and progressively reduced Ca2+ transients and cell shortening of HL-1 myocytes over 4 hours. These reductions were prevented by HSP-inducing pretreatments: mild heat shock, geranylgeranylacetone (GGA), and transfection with human HSP27 or the phosphorylation-mimicking HSP27-DDD. However, treatment with HSP70 or the phosphorylation-deficient mutant HSP27-AAA failed to alter tachycardia-induced Ca2+ transient and cell-shortening reductions, and downregulation (short interfering RNA) of HSP27 prevented GGA-mediated protection. Tachypacing (3 Hz) for 24 hours in vitro significantly reduced L-type Ca2+ current and action potential duration in canine atrial cardiomyocytes; these effects were prevented when tachypacing was performed in cells exposed to GGA. In vivo treatment with GGA increased HSP expression and suppressed refractoriness abbreviation and AF promotion in dogs subjected to 1-week atrial tachycardia-induced remodeling. In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model. These findings advance our understanding of the biochemical determinants of AF and suggest the possibility that HSP induction may be an interesting novel approach to preventing clinical AF.Keywords
This publication has 35 references indexed in Scilit:
- Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27American Journal of Physiology-Heart and Circulatory Physiology, 2006
- Effect of Atorvastatin on the Recurrence Rates of Atrial Fibrillation After Electrical CardioversionThe American Journal of Cardiology, 2006
- Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogsCardiovascular Research, 2006
- Association of High Intracellular, But Not Serum, Heat Shock Protein 70 With Postoperative Atrial FibrillationThe Annals of Thoracic Surgery, 2005
- Rapid stimulation causes electrical remodeling in cultured atrial myocytesJournal of Molecular and Cellular Cardiology, 2005
- Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscleAmerican Journal of Physiology-Cell Physiology, 2004
- Role of heat shock protein 27 in cytoskeletal remodeling of the airway smooth muscle cellJournal of Applied Physiology, 2004
- Role of protein kinase C in geranylgeranylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heartJournal of Molecular and Cellular Cardiology, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- In VitroAntiarrhythmic Effect of Prior Whole Body Hyperthermia: Implication of CatalaseJournal of Molecular and Cellular Cardiology, 1997